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a b s t r a c t
In the membrane-based bioartificial livers developed up to now, the hepatic cells were located either in
the fibers0 lumen or in the cartridge, with limited capacity for cell hosting. Here, we designed a
polysulfone (PSU) membrane with a double porosity level: (i) surface macroporosity emerging in
macrochambers accessible to hepatic cell colonization; (ii) microporosity to ensure gas and molecule
transfers between macrochambers and supernatant, as well as potential immune barrier. ESEM and
X-ray tomography confirmed that macrochambers accessed the membrane surface and were inter-
connected. Biocompatibility and performances of this PSU membrane with double porosity level were
compared to classical semi-permeable structures, following cell organization, cell proliferation and
liver specific activities over a 9 days incubation. Macrochambers were colonized by hepatic cells,
leading to higher albumin synthesis compared to control. Therefore, this membrane with double
porosity appeared as a promising support to offer an inner 3D environment adequate to cell
proliferation to form a liver-like tissue.
1. Introduction
Polysulfone (PSU) and derived polymers are commonly used to
elaborate synthetic membranes for extracorporeal blood filtration
systems. PSU filters offer a broad spectrum of properties in
agreement with different therapy modalities, combining high
mass transfers with hemocompatibility in clinical applications
(hemodialysis, plasmafractionation or plasmapheresis) [1,2]. The
success of this polymer can be explained by an adaptable porosity
of the membrane which selectively filters solutes and wastes
from plasma whilst retaining blood cells and proteins of interest
in the circulatory compartment [3,4].
PSU supports present several other advantages over many
polymers which are suitable for artificial systems in medical
studies [5]. PSU is a biocompatible polymer whose properties
allow the fabrication of different support geometries such as flat
membranes or hollow fibers. PSU polymer, which results from a
polycondensation, is stable in physiological conditions with a
good chemical resistance. Its stability to steam should be noted,
making sterilization possible by this largely used procedure. Its
hydrophobic and apolar properties favor the serum protein
adsorption, even if non-specific protein adsorption is limited on
PSU compared to other hydrophobic membranes [6]. Particularly,
PSU membrane bound a small proportion of albumin while
retaining protein associated with the coagulation cascade [7]. To
reduce protein adsorption, PSU can be mixed to a water-miscible
organic solvent to increase polymer wettability and viscosity.
Polyvinylpyrrolidone (PVP) or N-methyl-2-pyrrolidone (NMP) are
currently added to modify PSU in biomedical applications, then
increasing the wettability of the polymer and reducing platelet
adhesion on the surface [8,9].
In medical applications, PSU has been used for bioartificial
liver (BAL) design [10]. BALs aim at replacing metabolic functions
of the failing liver (such as biotransformation and protein synth-
esis) by hepatocyte incorporation in artificial systems. Thanks to
its physical, chemical and biological properties, PSU (modified or
not) membrane is then a material of choice in tissue engineered
BAL. Some of them have been experimented through clinical
trials, such as HepatAssist, MELS, AMC-BAL systems [10].
The PSU scaffold supports or is in close contact with liver cells.
The choice of scaffold design is crucial and must provide a
structured environment with tissue-specific mechanical proper-
ties to receive living cells [11]. The cells cultivated in this 3D
configuration present morphological and physiological character-
istics which are closely related to tissue-like structure and
functionality. Moreover, scaffold architecture has to respond to
the need of hosting large cell amounts to support and bridge
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injured livers before self-regeneration or transplantation. The
major limitation in engineering biosupports to enhance cell
density comes from the thickness of growing tissue which gives
rise to diffusion constraints. Oxygen and nutrient supply is
necessary to maintain living cells and the scaffold design has to
limit the distance between each cell and plasma or blood
compartment, to favor both metabolite and waste exchanges [12].
To circumvent these limitations, several configurations were
proposed in the past: high perfusion flow rate and use of a
microporous membrane in the case of HepatAssist, or use of
three types of hemofiltration membranes complexly woven in the
case of MELS. Rather than the membrane itself, the module design
or the perfusion process was optimized.
To improve the performances of membranes themselves, we
propose here a new structure of PSU membrane to promote the cell
density by offering a 3D architecture for growing cells while
favouring gas and metabolite diffusion, between cells and medium
supply on the one hand and among cells on the another one. This
double property relies on two levels of porosity: a macroporosity
that could favor the growth and activities of hepatocytes by
encouraging close contact between cells and a microporosity to
modulate gas and molecule transfers between each macrochamber
and between macrochambers and compartment supply. Our
approach consisted in following the behavior of a hepatocarcinoma
cell line, C3A cells, cultivated in contact with two types of poly-
sulfone membranes, the first one with double porosity level, and the
second one, used as control, with microporosity only.
2. Materials and methods
2.1. Fabrication of membranes
The membranes were prepared using a modified phase inver-
sion technique as shown in Fig. 1. A polymer solution was
prepared by dissolving polysulfone (PSU, Udel P3500, Solvay) in
N-methyl-2-pyrrolidone (NMP) at 60 1C during 24 h. The concen-
tration of PSU was set to 15% (wt). The polymer solution, at 20 1C,
was poured on a glass tape using a gardener knife to reach a
thickness about 250 mm. Two areas could be identified, covered or
not by the polyester track etched membrane (Sterlitech, USA).
Pore size of the track etched membrane was 10 mm. The track
etched membrane was first immersed in NMP in order to fill the
pores with NMP and was gently wiped to remove the excess
of NMP.
The glass plate was then immersed in a bath of water in 20 1C.
During the immersion, solvent exchange (both water and NMP)
occurred leading to the coagulation of the polymer and the
formation of the membrane. The solvent exchange was rather
homogeneous in the zone where the polymer solution was in
direct contact with the water whereas this exchange was loca-
lized within the pores of the track etched membrane in the zone
where the polymer was covered up with the polyester membrane.
With this method, two types of membrane were prepared in
the same condition. The part of the final membrane in direct
contact with water presented a homogeneous microporous struc-
ture obtained with the classical technique of phase inversion by
immersion in non-solvent. The rest of the membrane, where the
polymer solution was covered up with the track etched mem-
brane, had two porosity levels: the localized arrival of non-
solvent in the polymer solution induced the formation of large
macrochambers in the microporous membrane surface.
After the formation of the membrane, the track etched mem-
brane was removed and both types of membrane were separated
and washed in water milliQ to remove possible residues. Squares
of 1 cm2 were cut, sterilized in autoclave and stored in 4 1C until
cell seeding.
2.2. Structural characterization of membrane
The structural characterization was performed using environ-
mental scanning electron microscopy (ESEM) and X-ray tomo-
graphy in order to study the membrane at different scales and
dimensions (2D or 3D). A ESEM-FEG XL30 (Philips, France) was
used for ESEM in a classical way. The ESEM allowed studying the
structure in 2D with a high resolution. Pore size down to 10 nm
could be observed but in a small sample size, typically far below
1 mm. Complementary, X-ray tomography allowed the observa-
tion of 3D structure of large sample size but at low resolution. The
resolution was directly linked to the sample size: high resolution
allowed observing, in 3D, pore size down to 1–3 mm for a sample
size in millimeter range [13]. We used a nanofocus computed
tomography system NANOTOMs (GE Phoenix, Germany). The
samples were dried at room temperature. About 1800 images were
taken around the sample and a voxel size of around 2.2 mm was
reached so the smallest pore size that can be directly observed is
2.2 mm. A 3D volume of about 19621659612 mm3 was recon-
structed using the GE Phoenix software provided with the device.
Amiras software was used to visualize the 3D volume and to
separate the solid and void phases.
2.3. Cell culture
C3A human hepatocellular carcinoma cells provided by the
American Type Culture Collection (ATCC, reference CRL 10-741,
LGC Standards Sarl, Molsheim, France or http://www.lgcstandard
s-atcc.org/) were used. Cells were cultivated in Minimum Essen-
tial Medium Earle’s salts (MEM) supplemented with 1% L-gluta-
mine (200 mM), 0.5% penicillin–streptomycin (10,000 units/mL
and 10,000 mg/mL, respectively), 1% non-essential amino acids
(10 mM), 1% HEPES buffer solution (1 M), 1% sodium pyruvate
(100 mM) and 10% fetal calf serum, from Gibco (Cergy Pontoise,
France), in 37 1C and 5% CO2 in a humidified atmosphere. Cells
were initially plated in T-flask for expansion until they reached
80% confluence, after which they were trypsinized using 0.05%
trypsin in 1 mM EDTA.
Cells were seeded on squares (1 cm2) of the membranes with
double porosity, microporosity alone, and on Thermanox (Nunc
TM
)
used as control at a density of 2104 cells/cm2 in 50 mL of
complete medium. After incubation overnight in 37 1C, 5% CO2,
1 mL of complete medium was added on each well of 12-well
plates and changed every 2 or 3 days.
2.4. Cell morphological characteristics with ESEM
PSU membranes and Thermanox with C3A cells were fixed for
30 min with 2.5% glutaraldehyde in phosphate buffered saline
(PBS) at 4 1C and washed twice with water. To observe the cell
colonization within the porous structure of the PSU membranes,
Fig. 1. PSU membranes preparation. The polymer solution was poured on a glass
tape and a polyester track etched membranes was put at the surface of the
polymer solution.
samples were broken after freezing in liquid nitrogen. The
observations were performed with an environmental scanning
electron microscope (ESEM-FEG XL30, Philips, France).
2.5. Cell histology
After 8 days of culture, PSU membranes with C3A cells
were fixed as previously described. Samples were embedded in
Tissue-Teks and sectioned (10 mm thickness) in microtome (Jung
Frigocut Leica 2800 E). Sections were stained with Methylene
Blue 1% to visualize the cells under inverted light microscope
(Leica DMLB 30T).
2.6. Cell viability and proliferation
The cytotoxicity of PSU membranes was evaluated on C3A
cells by lactate deshydrogenase (LDH) activity. 200 mL of MEM
medium complemented with 1% fetal calf serum were added to
each sample and incubated at 37 1C, in a humidified 5% CO2 air
incubator. After 15 h of incubation, LDH activity in the medium
was measured (kit Promega, France) to estimate cell cytotoxicity.
Absorbance was expressed as a percentage of the maximum LDH
release obtained by lysing the cells in the presence of 0.8% Triton
X-100.
The metabolic activity was investigated using a colorimetric
test, Alamar Blues cell viability assay. The principle of the Alamar
Blue test rests on a fluorescent metabolic indicator, the resazurin,
which is reduced by metabolically-active cells to the fluorescent
compound, the resorufin. Alamar Blue reagent (10%) was added to
each membrane sample in complete medium and cells were
incubated for 1 h at 37 1C in a 5% CO2 atmosphere. The resulting
fluorescence intensity was measured using a SpectraFluor Plus
(TECAN, Switzerland) plate reader with an excitation wavelength
of 560 nm and an emission wavelength of 595 nm. MEM with 10%
of Alamar Blue without cells was used as reagent blank for the
fluorometric measurements.
Cell proliferation was measured after cell trypsinization and
EDTA treatment, and cell counting was performed using a
Malassez hemocytometer.
2.7. Determination of albumin and ammonia removal consumption
The secretion of albumin from C3A cells was measured by an
enzyme-linked immunosorbent assay (ELISA). Goat anti-human
albumin IgG antibodies were purchased from Cappel Laboratories
(Cochrainville, France).
Ammonia concentration was determined with a biochemistry
automatus (Konelab 20, Thermo, Cergy-Pontoise, France) using
kits from Randox (Mauguio, France).
2.8. Statistical analysis
Statistical analysis was performed using the Kruskal–Wallis
non-parametric test in order to compare the differences between
groups. Differences were considered as significant when po0.05
and are identified by n. The results are expressed as mean7
standard deviation of the mean. Each experiment was indepen-
dently repeated 3 times for the cell viability and proliferation
assays, and 2 times for the cell functionality tests.
3. Results
3.1. Structural characteristics of membranes
The surface and cross section characteristics of membranes
were investigated by ESEM and X-ray tomography (Figs. 2 and 3).
Fig. 2 shows the 3D reconstructed volumes of the two types of
membrane. For both, two images are presented: the reconstructed
volume (Fig. 2a, b) and for double porosity membrane, the one
with a section near macrochambers (Fig. 2c).
The cross section of the single porosity membrane demon-
strated a typical asymmetric structure formed by finger-like voids
Fig. 2. X-ray tomography virtual cross-sections of membranes with (a) single porosity and (b, c) double porosity at the upper surface. The white arrow indicates
macrochamber pore and the black arrow the 3D connections between macrochambers. Gray box size (a) 20152678 voxels or 4421157172 mm3 (b) and (c)
591314278 voxels or 1300691612 mm3.
(Fig. 2a). A denser layer was oriented to the active surface by open
fingers at the micrometric scale (Fig. 3b). These microfinger-like
structures were prolonged in deeper layer by macrofinger-like
chambers, which walls were highly porous and without direct
connection to the active surface. The top view surface (Fig. 3a)
was homogeneously recovered by micropores whose diameters,
calculated by ESEM, were 1.070.2 mm.
On the contrary, the asymmetrical structure of double porosity
membrane, as observed by tomography (Fig. 2b, c), presented
macrochambers which were largely open towards the active
surface. Cross section photograph from ESEM (Fig. 3d) with higher
resolution revealed that a third part of the membrane thickness
was filled by macrochambers and confirmed their direct opening
at the surface. The macrochambers displayed on a length of about
70 mm, to 200–300 mm when oriented subhorizontally, for a
diameter in the order of 50–60 mm. The macrochamber wall
possessed a highly porous, sponge-like structure visible in
Fig. 3e, with interconnected pores of a diameter in the range of
1 mm. The top view of the membrane with double porosity
presented a rough surface with uniformly distributed pores
(Fig. 3c). The mean pore diameter was about 50 mm and most of
pore sizes were above 20 mm.
The thickness of membrane with double porosity was about
180 mm whereas that of membrane with single porosity was
about 110 mm (Fig. 2).
3.2. Cell morphology, viability and proliferation
Hepatic cells were cultivated on the PSU membanes with
single or double porosity to follow the cellular distribution,
morphology and physiology over 9 days. Thermanox was used
as control for standard culture condition.
After few hours, hepatic cells attached and started prolifera-
tion on the surface of two types of membrane as they did on
Thermanox. At day 8, hepatic cells formed a homogeneous layer
at high cell density with tight cell–cell contact (Fig. 4a, b). The
hepatocyte viability, estimated by LDH assay, was above 96% on
two types of membranes, or on control, whatever the delay of
culture (Fig. 6a).
Hepatic cell growth was measured by cell counting after
detachment using trypsin. Cells appeared to proliferate equally
on the membranes with double or single porosity, reaching the
confluence state after 8 days (Fig. 6b). Similar data were obtained
on Thermanox, although a slightly higher growth of about 20%,
Fig. 3. ESEM micrographs of membranes with (a, b) single porosity, (c,d,e) double porosity showing (a, c) top of view of active layer, (b, d) cross section of membranes, and
(e) macrochamber with high magnification.
determined by cell numeration, was observed after day 4. These
results, concerning the cell viability and proliferation, were
confirmed by the Alamar Blue test. Data showed no significant
difference between both types of membrane and with Thermanox
(Fig. 6c).
On the membrane with double porosity, cells spread inside the
macrochamber, as seen from ESEM view (Fig. 4b). Cross section of
the membrane at high magnification (Fig. 4c) clearly showed
that chambers were colonized by hepatic cells. In order to observe
the inner structure of the membrane with double porosity,
membrane cuts after 9 days of cell culture were stained with
Methylene Blue (Fig. 5). The ESEM micrograph demonstrated
effective cell invasion in the deeper parts of macrochambers,
about 100 mm from the contact surface.
3.3. Cell functionality
Hepatic cell functions were assessed by two parameters –
ammonia and albumin concentrations – which were measured in
the supernatant, on days 2, 4, 8 and 9. The amounts of ammonia
release were similar for the three materials at a level of 0.80 mmol/
24 h/106 cells. No significant difference was noted during the culture
period (Fig. 7a). Albumin release in the culture medium was
significantly higher when C3A cells were grown on membrane with
the double porosity in comparison to Thermanox (po0.05), whatever
the time of culture. Such a difference is also observed between the
double and single porosity membrane from day 2 to 9, being
significant at day 8 (4.6 mg/24 h/106 cells versus 4.3 mg/24 h/106 cells
for membrane with double porosity and membrane with simple
porosity, respectively) (po0.05) (Fig. 7b). Because the macrovoids0
mouths are large enough to allow cells in, we consider that this
difference in albumin concentration is not the result of a difference in
permeability to proteins or other metabolites between the membrane
and the control. In addition, albumin production was lower at day
2 in comparison with other time points, regardless the type of
support. These data were consistent with the characteristics of the
C3A cell line: they have been reported to secrete more albumin as
they become confluent [14].
4. Discussion
The semi-permeable membrane is one of the essential com-
ponents of BAL device as it acts as a selective barrier between the
Fig. 4. ESEM observation of hepatic cells after 8 days of culture on: (a) membrane with single porosity, (b, c) membrane with double porosity level by over view and cross
section respectively, both showing a macrochamber.
Fig. 5. Histological staining of a cross section of PSU membrane with double
porosity showing cell invasion in macrochamber (arrow) 100.
patient’s plasma or blood and liver tissue formed from hetero-
logous or xenogenic hepatocytes. Ideally, membranes used as
scaffold should present the following properties: (i) biocompat-
ibility, dependent of the chemical composition and surface rough-
ness, essential to initiate the liver tissue formation; (ii) structural
3D organization which may guide the development of growing
tissue and favor cell metabolism and specific liver functions; and
(iii) microporosity to selectively transfer oxygen and nutrients,
remove cell catabolites, ensure effective detoxification functions
and avoid immune responses.
Synthetic polymeric membranes can be modified in order to
respond to selective filtration and biocompatibility properties for
blood and liver tissue requirements. The chemical composition
[15–17], the surface characteristics by grafting functional groups
[18–21] or the modification of porosity and pore diameter of PSU
membranes [22–25] are some of numerous strategies to improve
mass transfers, humoral immune responses and to influence the
hepatocyte behavior cultivated on these membranes.
Here, we propose to manufacture and investigate a PSU
membrane characterized by two porosity levels: a microporosity
maximizing the diffusion and exchange of nutrients throughout
the membrane wall and soluble mediators between the growing
cells, and a macroporosity optimizing tissue function as it was
described for bone in-growth [26].
The technique set up to obtain this double porosity was very
delicate and did not change the native membrane properties. We
seeded C3A cells, a hepatic cell line, on two types of porous
membrane and followed the cell behavior over 9 days as a marker
of polymeric membrane cytocompatibility. C3A cells were applied as
a widely accepted cellular model for assessment of hepatocyte
behavior. These cells were also used in the extracorporeal assist
device system in a pilot-controlled trial (ELAD) [27].
The hydrophobic properties of PSU polymer are not ideal for
cell adhesion and spreading in comparison with hydrophilic
materials [6]. This drawback could be avoided by a precoating
step with specific proteins, like collagen or fibronectin, which
recovered the surface and increased the hydrophilic characteristic
of PSU. In our case, the hydrophobic properties of PSU membranes
were changed by a precoating step in completed medium culture
before cell seeding, enabling the deposit of an active serum
protein layer on the PSU surface. The data presented here
confirmed a well organized monolayer of polygonal C3A cells on
PSU membrane, whatever the porosity type, and was comparable
to cell organization on standard tissue culture substrates, such as
Thermanox.
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porosity and Thermanox: (a) ammonia release; (b) albumin synthesis. Black bars:
membrane with double porosity; gray bar: membrane with single porosity; white
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two independent experiments. nSignificantly different (po0.05) with Kruskal–
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The cell numeration indicated no difference between the two
types of PSU membranes: from day 2, C3A cells proliferated equally
on PSU membranes with double porosity or with single one. The
slowing down of growth between both PSU membranes and
Thermanox was not due to cell death because the viability, mea-
sured by the LDH assay, was similar in the two conditions and
superior to 96%. This data was confirmed by the Alamar Blue test, a
colorimetric assay used to quantify the cell viability and growth
[28]. Then, our results confirmed the good cytocompatibility of PSU
membranes, although C3A growth was more favorable on Therma-
nox, as its hydrophilic characteristic might let it expect [15].
The analysis of some hepatocyte functions showed that C3A
cells maintained the ammonia and albumin release when culti-
vated on membrane with double porosity, compared to controls,
i.e. membrane with single porosity and Thermanox support. The
difference between albumin production rates on the two types of
PSU membrane at day 8 might be a consequence of cell organiza-
tion in macropores. The stuffy space of macrochambers could limit,
under the static culture conditions employed here, the diffusion of
mediators in the culture medium and concentrate secreted mole-
cules near the hepatocytes. The tissue development in macro-
chamber might concentrate mitogens and hepatotrophic factors
then enabling a stimulation of albumin secretion [29]. This
hypothesis was reinforced by the ESEM observations which clearly
showed the cell capacity to colonize the macrochambers during
the culture period. Hepatocytes were spread on the macrochamber
surfaces and invaded the 3D structure on about 70 mm of depth.
In most cases, BAL devices use hollow fibers whose chemical,
mechanical and morphological properties of membranes are
directly associated to BAL safety and performance. In hollow fiber
bioreactor systems, fibers provide luminal compartment for
plasma or blood perfusion and the hepatocytes are grown in the
extracapillary space, on the surface of the hollow fiber membrane,
which generally presents a single level of porosity (systems ELAD,
MELS, Oxy-HFB, LLS-HALSS) [30]. Cells organize in large aggre-
gates or in tissue-like organoids in contact with fiber membrane.
The membranes act as a barrier protecting cells from shear stress
and avoiding direct contact with immune molecules, but could be
a limiting factor to optimal exchanges [31]. The extracapillary
space has to host large amounts of liver cells, ideally a mass of at
least 20% of the normal liver, to recover an optimal functionality
[32]. In all of these cases, the capacity for cell hosting is limited by
the available void volume in the cartridge or in the lumen of the
fibers. In contrast, the membrane with double porosity level
described here presented an original internal structure to respond
to this space constraint. Macrochambers may be a guide to the
hepatocyte aggregate development, enabling high cell density in
controlled sizes. The microporosity of macrochamber walls could
assume bidirectional mass transfers and increase contact surface
between cells and flow compartment.
In the context of development of bioartificial liver systems, C3a
cell line is not the ultimate cell choice. The macrochambers of
double porosity membrane could be an opportunity to overcome
some limitations inherent to the in vitro culture of primary hepato-
cytes. These cells, considered as the most adequate model for
applications in liver tissue engineering, are well known to lose their
liver-specific functions when maintained in conventional culture
conditions. A high degree of functionality was nevertheless obtained
cultivating these cells in aggregates or in 3D in polyurethane foaming
membranes [33,34]. The macrochambers in the PSU membrane could
be a suitable model to guide the 3D primary hepatocyte organization
while controlling the cell aggregate diameter.
Based on the encouraging biological data obtained with flat
sheet membranes, and the real potential for cell colonization in
the macrochambers, such membrane with double porosity level
could be integrated in microfluidic biochip [35] or at larger scale,
in flat membrane bioreactor to develop new cryopreservation
methods or to supply liver failure [36,37]. In flat membrane
bioreactor, it would thus be possible to combine high mass
transfer properties due to diffusion and convection achieved
under perfusion conditions, and high cell density offered by the
macropore area.
5. Conclusion
In the present study, a membrane with double porosity level was
formulated and characterized for an application in liver tissue
engineering. The membrane appeared to be biocompatible and offer
a 3D environment into its structure that can be colonized by
hepatocytes, leading to a potentially high cell density. Cell toxicity
was not observed and functions were maintained over 9 days. These
encouraging results obtained with PSU membranes need now to be
confirmed by hybrid liver support devices in tissue engineering.
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